[Anti-inflammatory effect of bimetopyrol. 3. Possible active substance and site of action].
D000284:Administration, Oral; D000315:Adrenalectomy; D000818:Animals; D000840:Anisoles / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D001665:Binding Sites; D004487:Edema / Q000188:drug therapy; D007213:Indomethacin / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D011758:Pyrroles / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D000840:Anisoles; D000893:Anti-Inflammatory Agents; D011758:Pyrroles; D010653:Phenylbutazone; D007213:Indomethacin